Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls : a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey

Leonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, Jessica Day, Parikshit Sen, Jucier Gonçalves Junior, James B. Lilleker, Mrudula Joshi, Vishwesh Agarwal, Sinan Kardes, Minchul Kim, Marcin Milchert, Ashima Makol, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ioannis Parodis, Albert Selva O'Callaghan, Elena NikiphorouAi Lyn Tan, Tulika Chatterjee, Lorenzo Cavagna, Miguel A. Saavedra, Nelly Ziade, Johannes Knitza, Masataka Kuwana, Arvind Nune, Oliver Distler, Döndü Üsküdar Cansu, Lisa Traboco, Suryo Angorro Kusumo Wibowo, Erick Adrian Zamora Tehozol, Jorge Rojas Serrano, Ignacio García-De La Torre, Chris Wincup, John D. Pauling, Hector Chinoy, Vikas Agarwal, Rohit Aggarwal, Latika Gupta

Producción científica: Contribución a una revistaArtículoInvestigaciónrevisión exhaustiva

Huella

Profundice en los temas de investigación de 'COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls : a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey'. En conjunto forman una huella única.
Clasificar por

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science